- Article metrics
- Last updated: Wed, 25 Feb 2026 10:41:17 Z
Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
Access & Citations
-
- 918
- Article Accesses
-
- Not available
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
